Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Dong Wha Park |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
A preliminary investigation of α-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia / Eosu Kim en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 2 (Abril)
[artículo]
Título : A preliminary investigation of α-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia Tipo de documento: texto impreso Autores: Eosu Kim, Autor ; Dong Wha Park, Autor ; Song Hee Choi, Autor Fecha de publicación: 2023 Artículo en la página: pp. 138-146 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antioxidantes, Antipsicóticos, Apetito - efectos del medicamento, Indice de masa corporal, Colesterol, Depresión, Obesidad, Esquizofrenia. Resumen: Weight gain and other metabolic disturbances have now become discouraging, major side effects of atypical antipsychotic drugs (AAPDs). The novel strategies required to counteract these serious consequences, however, should avoid modulating the activities of the neurotransmitter receptors involved because those receptors are the therapeutic targets of AAPDs. Link: ./index.php?lvl=notice_display&id=30856
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 2 (Abril) . - pp. 138-146[artículo] A preliminary investigation of α-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia [texto impreso] / Eosu Kim, Autor ; Dong Wha Park, Autor ; Song Hee Choi, Autor . - 2023 . - pp. 138-146.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 2 (Abril) . - pp. 138-146
Palabras clave: Antioxidantes, Antipsicóticos, Apetito - efectos del medicamento, Indice de masa corporal, Colesterol, Depresión, Obesidad, Esquizofrenia. Resumen: Weight gain and other metabolic disturbances have now become discouraging, major side effects of atypical antipsychotic drugs (AAPDs). The novel strategies required to counteract these serious consequences, however, should avoid modulating the activities of the neurotransmitter receptors involved because those receptors are the therapeutic targets of AAPDs. Link: ./index.php?lvl=notice_display&id=30856